集中治療室で得られた筋肉縮と重症病の弱さ:長期的な回復戦略の見直し
1Division of Disaster and Emergency Medicine, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, Japan.
Acute and critical care
|September 3, 2025
まとめ
集中治療室 (ICU) に 入院した患者は 筋肉の衰弱や衰弱に 直面し 長期にわたる障害を 引き起こすことが多いのです 早期のリハビリテーションと栄養補助は これらの衰弱状態の予防と緩和の鍵です
科学分野:
- クリティカル ケア 医療
- 神経学
- リハビリテーション医学
背景:
- 集中治療室 (ICU) で発症した筋肉縮と筋力低下は,集中治療後の症候群 (PICS) に大きく寄与する.
- ICUでの生存率の改善は,多くの患者にとって長期的な機能的な結果に転じていない.
- 持続的な機能障害は,PICS患者の社会復帰を妨げています.
研究 の 目的:
- ICUで得られた筋肉縮と弱さの病因,評価,予防について見直す.
- 筋縮ゼロプロジェクトから得られた結論をまとめます
- 効果的なマルチモダルの介入を特定し,構造化されたフォローアッププログラムの必要性を強調する.
主な方法:
- 筋縮ゼロプロジェクトからの観察と介入研究のレビュー
- 筋肉縮における炎症の役割に関する研究の分析
- 超音波検査や尿検査などの診断方法の評価
- リハビリテーション,電気刺激,栄養支援を含む予防戦略の評価
主要な成果:
- 炎症,特に中性粒子の浸透は,筋肉縮の病原性において極めて重要です.
- 超音波は筋肉の弱さを検出するのに非常に正確です.尿中のチチンは筋肉の劣化のための有望なバイオマーカーです.
- 多様療法 (早期のリハビリテーション,神経筋肉の電気刺激,振動療法,栄養補助) は,筋肉の縮小と弱さを効果的に軽減します.
- 現在のPICSのフォローアップシステムは 十分に開発されていない.
結論:
- 身体的リハビリテーションと栄養療法を組み合わせた継続的なマルチモダルの介入アプローチは,ICUで得られた筋肉の問題を管理するために不可欠です.
- 構造化されたフォローアッププログラムは,PICSの長期的な課題に対処するために不可欠です.
- PICS患者に対する総合的なケア戦略のさらなる研究と実施が必要である.
関連する概念動画
Cross-bridge Cycle
120.4K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
120.4K
Acute Kidney Injury VI: Nursing Management
178
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
178
Muscle Recovery and Fatigue
3.5K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
3.5K
Disorders of the Skeletal Muscle
1.4K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.4K
Acute Respiratory Failure-V
284
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
284
Myasthenia Gravis: Overview and Treatment
2.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.4K


